siRNA/shRNA-based therapy (CEA)

N/A

Report date: 2025/03/20 20:00:06

NME

Base Information

Drug NamesiRNA/shRNA-based therapy (CEA)

Drug Alias NameN/A

ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > short hairpin RNASmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA

Mechanisms of ActionHuntingtin modulators

TargetsHuntingtin

Therapy Area/IndicationsHuntington Disease

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryFrance

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesCommissariat A L'Energie Atomique

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesCommissariat A L'Energie Atomique

Active IndicationsN/A

Inactive IndicationsHuntington Disease

Other Information

ATC CodeN/A